chartexchange

Clearmind Announces Patent Publication in Japan Covering Treatment for Neurological Movement Disorder

GlobeNewswire Inc. | Oct 8, 2026 7:32 AM EDT

Published patent application covers 3-MMC-based treatment of dyskinesia, including in combination with Palmitoylethanolamide (PEA)

Read original article